HomeAUPH • NASDAQ
add
Aurinia Pharmaceuticals Inc
Previous close
$14.37
Day range
$13.87 - $14.51
Year range
$6.83 - $16.54
Market cap
1.85B USD
Avg Volume
972.13K
P/E ratio
6.74
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 77.11M | 28.81% |
Operating expense | -6.37M | -126.59% |
Net income | 210.79M | 14,651.15% |
Net profit margin | 273.35 | 11,337.24% |
Earnings per share | 1.53 | 15,200.00% |
EBITDA | 47.80M | 278.07% |
Effective tax rate | -490.62% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 397.94M | 11.02% |
Total assets | 751.59M | 36.49% |
Total liabilities | 170.26M | -1.68% |
Total equity | 581.33M | — |
Shares outstanding | 132.97M | — |
Price to book | 3.27 | — |
Return on assets | 16.78% | — |
Return on capital | 19.52% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 210.79M | 14,651.15% |
Cash from operations | 45.67M | 51.65% |
Cash from investing | -36.76M | -193.71% |
Cash from financing | -1.89M | 91.80% |
Net change in cash | 7.02M | -84.83% |
Free cash flow | 48.19M | 14.75% |
About
Founded
2012
Headquarters
Website
Employees
128
